Document is current

Dipeptidyl peptidase 4 inhibitor linagliptin can decrease the dosage of erythropoiesis-stimulating agents in patients on hemodialysis

Crossref DOI link: https://doi.org/10.1186/s41100-016-0058-7

Published Online: 2016-09-28

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy